Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab EmtansineTaha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2024
Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitorsGozde Kavgaci, Deniz Can Guven, Yunus Kaygusuz, et al.
The Oncologist|February 3, 2024
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic ReviewDeniz Can Guven, Gozde Kavgaci, Enes Erul, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 21, 2021
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapyDeniz C Guven, Gozde Kavgaci, Oktay H Aktepe, et al.
Expert Review of Molecular Diagnostics|February 26, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Anti-Cancer Drugs|February 2, 2023
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitorsDeniz Can Guven, Deniz Aral Ozbek, Taha Koray Sahin, et al.
Cancer Biomarkers : Section a of Disease Markers|December 27, 2021
The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitorsDeniz Can Guven, Oktay Halit Aktepe, Melek Seren Aksun, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2024
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) studyHasan Cagri Yildirim, Caner Kapar, Baris Koksal, et al.
Pageof 2